Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests Self-Management program to ease pain and boost opioid treatment

NCT ID NCT06855732

Symptom relief Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 19, 2026 · Updated 2 times

Summary

This study tests a 12-week Pain Self-Management (PSM) program for people with chronic pain and opioid misuse or opioid use disorder. Researchers want to see if the program helps participants manage pain better and stay in treatment for opioid use. About 204 adults from primary care clinics will take part, with some receiving the PSM program and others getting standard care. Participants will complete surveys over 9 months to track their progress.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pain Self-Management (PSM) program
What this could lead to
If it works, this could offer a practical, non-drug way to help people with chronic pain and opioid use disorder feel better and stay engaged in their recovery.
What could go wrong
This is a relatively small, early-stage trial comparing the program to usual care. The results may not apply to everyone, and there are risks like psychological distress from discussing difficult topics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 204 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Adults at least 18 years old 2. Ability to speak, read, and understand English 3. Capable of providing informed consent 4. Access to phone and/or internet 5. Current (defined as at least 1 primary care visit in the past 3 years) or new (confirmed appointment) primary care patient at a participating clinic 6. Must meet criteria for OUD or opioid misuse based on at least one of the following: 1. OUD Misuse Screening score of 3 or more (sometimes or more) on at least one of the questions 2. Meets criteria for DSM-5 Opioid Use Disorder on MINI-J 3. Documented diagnosis of Opioid use Disorder (OUD) 7. Have bothersome (Grade 2) or high impact chronic pain (Grade 3), based on the Graded Chronic Pain Scale-Revised (GCPS-R) Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in this study: 1. Under 18 years of age 2. Have cancer-related pain 3. Are currently in jail, prison, overnight/residential facility as required by court of law or have pending legal action that could prevent participation in study activities 4. Have received prescribed, administered, or dispensed MOUD (buprenorphine, methadone, naltrexone) as maintenance treatment for OUD (excluding acute or short-term (\< 7 days) use of these medications to manage opioid withdrawal or pain management) within the past 90 days 5. Had an intentional suicide attempt within the past 3 months The investigators will not exclude individuals with common comorbidities, such as depression, anxiety, or alcohol, methamphetamine, and other substance use disorders.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior, Addictive Chronic Pain chronic pain syndrome opiate dependence opioid abuse Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain Opioid misuse and addiction Opioid use disorder

Contacts and locations

Locations

  • Community Medicine, Inc.

    Pittsburgh, Pennsylvania, 15213, United States

  • Comprehensive Care Practice

    Baltimore, Maryland, 21224, United States

  • Harpers Ferry Family Medicine (WVU Medicine)

    Harpers Ferry, West Virginia, 25425, United States

  • Renaissance Family Practice - Aspinwall Office

    Pittsburgh, Pennsylvania, 15215, United States

  • Renaissance Family Practice - Glenshaw Office

    Glenshaw, Pennsylvania, 15223, United States

  • Renaissance Family Practice - Hampton Office

    Allison Park, Pennsylvania, 15101, United States

  • Renaissance Family Practice - Harmarville Office

    Pittsburgh, Pennsylvania, 15238, United States

  • Renaissance Family Practice - Millvale Office

    Pittsburgh, Pennsylvania, 15209, United States

  • Renaissance Family Practice - Penn Hills Office

    Verona, Pennsylvania, 15147, United States

  • Renaissance Family Practice - RIDC Office

    Blawnox, Pennsylvania, 15238, United States

  • St. Joseph's Rural Health Clinic (WVU Medicine)

    Buckhannon, West Virginia, 26201, United States

  • UPMC General Internal Medicine-Montefiore

    Pittsburgh, Pennsylvania, 15213, United States

  • UPMC General Internal Medicine-Shadyside (Shea Medical Center)

    Pittsburgh, Pennsylvania, 15232, United States

  • UPMC General Internal Medicine-South

    West Mifflin, Pennsylvania, 15122, United States

  • UPMC General Internal Medicine-Turtle Creek

    Turtle Creek, Pennsylvania, 15145, United States

  • WVU Medicine Primary Care

    Shepherdstown, West Virginia, 25419, United States

  • WVU Medicine University Town Centre

    Morgantown, West Virginia, 26501, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.